William Roberts | executive |
John Bailey | executive |
Andrew Perry | executive |
Rajesh Malik | executive |
John Umstead | executive |
Gil Blum | analyst |
Joseph Thome | analyst |
Priyanka Grover | analyst |
Laura Prendergast | analyst |
David Nierengarten | analyst |
Good day, and thank you for standing by. Welcome to the G1 Therapeutics First Quarter 2024 Financial Results. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Will Roberts.